Sanford-Burnham News Archive

Burnham Institute for Medical Research Appoints Zaugg as Vice President, Business Development

LA JOLLA, Calif. , March 19, 2007

Burnham Institute for Medical Research has appointed Robert H. Zaugg, Ph.D. to the position of Vice President, Business Development.  Dr. Zaugg will be responsible for the business development activities of the Institute, including technology licensing and establishment of strategic alliances in support of our scientists in La Jolla, Santa Barbara and at Lake Nona in Orlando, Florida.

Dr. Zaugg has contributed to the successful closing of deals aggregating greater than $500 million over 20 years in companies spanning from startup biotech environments to large pharmaceutical corporations.  In recent years, Dr. Zaugg has worked as an independent consultant, serving as Interim CEO of several California biotech companies, including DermAegis, Inc., which he also co-founded, and Optime Therapeutics.  Dr. Zaugg's prior affiliations include: General Manager of GTS Proteomics; Vice President of Business Development at Vical, Inc.; Director of Business Development at Triton (now Berlex) Biosciences; Assistant Director of Technology Assessment at Sandoz (now Novartis).  Dr. Zaugg also held positions as Senior Scientist at Teknekron Research in McLean, VA, and served as an intern in the United States Senate as an advisor to the Subcommittee on Science, Technology and Space.  Dr. Zaugg trained as a postdoctoral fellow at MIT where his work on immunoglobulin biochemistry was supported by a fellowship from the prestigious Damon Runyon-Walter Winchell Cancer Foundation.  He has earned degrees from UCLA (B.A.), Northwestern University (M.S., Ph.D.), and New York University (M.B.A.).

"Dr. Zaugg is joining the Institute at an exciting time as we establish bicoastal operations,” stated Karin Eastham, Executive Vice President and Chief Operating Officer.  “I look forward to working with Dr. Zaugg to forge the alliances needed to expedite development of Burnham discoveries to detect, treat and cure disease."

About Sanford-Burnham Medical Research Institute


Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at sanfordburnham.org.

Sanford-Burnham can also be found on Facebook at facebook.com/sanfordburnham and on Twitter @sanfordburnham.

News & News and Press - Sanford-Burnham Boilerplate
Sign In Skip Navigation Links Skip navigation links
News Archive
Sanford-Burnham In The News
Media Contacts and Guidelines
News Search
Paper of the Week
Quarterly Science Highlights
Multimedia Resources